uniQure (QURE) Enterprise Value (2015 - 2026)
uniQure (QURE) posted quarterly Enterprise Value of -$810.3 million for Q2 2026, down 114.96% year-over-year from $5.4 billion in Q2 2025, and down 38.15% quarter-over-quarter from -$586.6 million in Q1 2026.
uniQure (QURE) Enterprise Value (2015 - 2026) Analysis & Trends
uniQure's Enterprise Value history runs 12 years deep, the most recent figure standing at -$810.3 million for Q2 2026.
- In Q2 2026, Enterprise Value fell 114.96% year-over-year to -$810.3 million; the TTM figure through Jun 2026 stood at -$810.3 million (down 114.96% YoY), while the FY2025 annual figure was -$622.5 million, down 69.39% from the prior year.
- Enterprise Value for Q2 2026 stood at -$810.3 million, down from -$586.6 million in the prior quarter.
- The five-year high for Enterprise Value was -$315.3 million in Q1 2023, with the low at -$810.3 million in Q2 2026.
- The 5-year median for Enterprise Value is -$524.7 million (2022), against an average of -$523.4 million.
- The sharpest annual moves came in 2024 and 2026: Enterprise Value surged 40.52% in 2024, then sank 114.96% in 2026.
- uniQure's Enterprise Value stood at -$352.8 million in 2022, then slumped by 75.12% to -$617.9 million in 2023, then soared by 40.52% to -$367.5 million in 2024, then tumbled by 69.39% to -$622.5 million in 2025, then slumped by 30.17% to -$810.3 million in 2026.
- Business Quant data shows QURE's Enterprise Value at -$810.3 million in Q2 2026, -$586.6 million in Q1 2026, and -$622.5 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | uniQure | 3.37 Bn | 3.37 Bn | 5.49 Mn | -810.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -810.34 Mn |
| Mar 31, 2026 | -586.55 Mn |
| Dec 31, 2025 | -622.54 Mn |
| Sep 30, 2025 | -694.25 Mn |
| Jun 30, 2025 | -376.97 Mn |
| Mar 31, 2025 | -409.01 Mn |
| Dec 31, 2024 | -367.52 Mn |
| Sep 30, 2024 | -435.24 Mn |
| Jun 30, 2024 | -524.43 Mn |
| Mar 31, 2024 | -555.68 Mn |
| Dec 31, 2023 | -617.89 Mn |
| Sep 30, 2023 | -658.91 Mn |
| Jun 30, 2023 | -628.59 Mn |
| Mar 31, 2023 | -315.34 Mn |
| Dec 31, 2022 | -352.84 Mn |
| Sep 30, 2022 | -440.31 Mn |
| Jun 30, 2022 | -500.52 Mn |
| Mar 31, 2022 | -524.89 Mn |
| Dec 31, 2021 | -556.26 Mn |
| Sep 30, 2021 | -578.46 Mn |